Список литературы

1. Каприн А.Д., Старинский В.В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность) - М.: МНИОИ им. П.А. Герцена филиал ФГБУ "НМИРЦ" Минздрава России, 2017., с. 11, 15, 16

2. Давыдов М.И. Энциклопедия клинической онкологии. Москва, ООО "РЛС-2004", 2004

3. Л.Х. Собин, М. Господарович, К. Виттекинд. TNM. Классификация злокачественных опухолей. - 7-е издание - М.: Логосфера, 2011, стр. 45 - 49.

4. Teymoortash, A. Current advanced in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer / A. Teymoortash, J.A. Werner // GMS Curr. Top Otorhinolaryngol. Head Neck Surg. - 2012. - Vol. 11. - P. 04.

5. Soo KC, Tan EH, Wee J, Lim D, Tai BC, Khoo ML, et al.: Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005; 93: 279 - 86.

6. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al.: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945 - 52.

7. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al.: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571 - 8.

8. Athmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995 Sep 14. 333(11): 693 - 8. [Medline].

9. Greene MH, Fraumeni JF, Hoover R. Nasopharyngeal cancer among young people in the United States: racial variations by cell type. J Natl Cancer Inst. 1977 May. 58(5): 1267 - 70. [Medline].

10. Berry MP, Smith CR, Brown TC, Jenkin RD, Rider WD. Nasopharyngeal carcinoma in the young. Int J Radiat Oncol Biol Phys. 1980 Apr. 6(4): 415 - 21. [Medline].

11. Sham JS, Poon YF, Wei WI, Choy D. Nasopharyngeal carcinoma in young patients. Cancer. 1990 Jun 1. 65(11): 2606 - 10. [Medline].

12. Ung A, Chen CJ, Levine PH, Cheng YJ, Brinton LA, Chen IH, et al. Familial and sporadic cases of nasopharyngeal carcinoma in Taiwan. Anticancer Res. 1999 Jan - Feb. 19(1B): 661 - 5. [Medline].

13. Lu CC, Chen JC, Tsai ST, Jin YT, Tsai JC, Chan SH, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer. 2005 Jul 10. 115(5): 742 - 6. [Medline].

14. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer. 2000 Feb 1. 85(3): 358 - 63. [Medline].

15. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976 Jan 15. 17(1): 1 - 7. [Medline].

16. Gastpar H, Wilmes E, Wolf H. Epidemiologic, etiologic and immunologic aspects of nasopharyngeal carcinoma [NPC]. J Med. 1981. DA - 19820212(4): 257 - 84. [Medline].

17. Leung SF, Zee В, Ma BB, Hui EP, Mo F, Lai M, et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol. 2006 Dec 1. 24(34): 5414 - 8. [Medline].

18. Ingersoll L, Woo SY, Donaldson S, et al. Nasopharyngeal carcinoma in the young: a combined M.D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys. 1990 Oct. 19(4): 881 - 7. [Medline].

19. Ayan I, Altun M. Nasopharyngeal carcinoma in children: retrospective review of 50 patients. Int J Radiat Oncol Biol Phys. 1996 Jun 1. 35(3): 485 - 92. [Medline].

20. Cooper JS, Cohen R, Stevens RE. A comparison of staging systems for nasopharyngeal carcinoma. Cancer. 1998 Jul 15. 83(2): 213 - 9. [Medline].

21. Pharynx. Edge SB, Byrd dR, Compton cc, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010. 41 - 56.

22. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998 Apr. 16(4): 1310 - 1317. [Medline].

23. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progres. Int J Radiat Oncol Biol Phys. 1996 Jun 1. 35(3): 463 - 9. [Medline].

24. Chan AT, Teo PM, Leung TW, Johnson PJ. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer. 1998 Mar 15. 82(6): 1003 - 12. [Medline].

25. Gu MF, Liu LZ, He LJ, Yuan WX, Zhang R, Luo GY, et al. Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma. Int J Cancer. 2012 May 18. [Medline].

26. Douglass EC, Fontanesi J, Ribiero RC. Improved long-term disease free survival in nasopharyngeal carcinoma in childhood and adolescence. Proc ASCO. 1996. 15: 467.

27. Rodriguez-Galindo C, Wofford M, Castleberry RP, et al. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer. 2005 Feb 15. 103(4): 850 - 7. [Medline].

28. Wolden SL, Steinherz PG, Kraus DH, Zelefsky MJ, Pfister DG, Wollner N. Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. Int J Radiat Oncol Biol Phys. 2000 Mar 1. 46(4): 859 - 64. [Medline].

29. Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med. 2016 Oct 8. [Medline]. [Full Text].

30. Li JG, Yuan X, Zhang LL, Tang YQ, Liu L, Chen XD, et al. A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma. Cancer. 2013 Sep 1. 119(17): 3170 - 6. [Medline].

31. Ozyar E, Selek U, Laskar S, et al. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol. 2006 Oct. 81(1): 39 - 46. [Medline].

32. Casanova M, Bisogno G, Gandola L, Cecchetto G, DiCataldo A, Basso E, et al. A prospective protocol for nasopharyngeal carcinoma in children and adolescents. The Italian rare tumors in pediatric age (TREP) project. Cancer. 2011. Epub ahead of print: [Medline].

33. Orbach D, Brisse H, Helfre S, Klijanienko J, Bours D, Mosseri V, et al. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects. Pediatr Blood Cancer. 2008 Apr. 50(4): 849 - 53. [Medline].

34. Louis CU, Paulino AC, Gottschalk S, et al. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007 Jul. 29(7): 500 - 5. [Medline].

35. Lee N, Xia P, Quivey JM, Sultanem K, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002 May 1. 53(1): 12 - 22. [Medline].

36. Laskar S, Bahl G, Muckaden M, Pai SK, Gupta T, Banavali S, et al. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Nov 1. 72(3): 728 - 36. [Medline].

37. Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol. 1999 Oct. 17(10): 3283 - 90. [Medline].

38. Kwong DL, Wei WI, Sham JS, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys. 1996 Sep 1. 36(2): 281 - 9. [Medline].

39. Teo PM, Chan AT, Lee WY, Leung TW, Johnson PJ. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Int J Radiat Oncol Biol Phys. 1999 Jan 15. 43(2): 261 - 71. [Medline].

40. Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft fьr Pдdiatrische Onkologie und Hдmatologie. Cancer. 1997 Sep 1. 80(5): 951 - 9. [Medline].

41. Serin M, Erkal HS, Elhan AH, Cakmak A. Nasopharyngeal carcinoma in childhood and adolescence. Med Pediatr Oncol. 1998 Dec. 31(6): 498 - 505. [Medline].